View Press Releases
-
ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies
SCHILTHIGHEIM, FRANCE - Oct 28, 2019 - For researchers looking to accelerate the development of new immunotechnologies, ProteoGenix has created 2 new naïve rabbit and human antibody phage display libraries
Oct 28, 2019
-
A prediction of gene sequencing application areas and scale by CD Genomics
SHIRLEY, NY, UNITED STATES - Oct 28, 2019 - The upstream of the gene sequencing industry is the supply of sequencing instruments, sequencing reagents and consumables
Oct 27, 2019
-
BOC Sciences Upgrades Bioconjugation Service to Help Advance Targeted Drug Delivery Research
SHIRLEY, NY, UNITED STATES - Oct 22, 2019 - Targeted drug delivery is by no means easy task, but luckily bioconjugation can be of great assistance
Oct 27, 2019
-
Creative Proteomics Provides Glycosylation Service for Lab Research
SHIRLEY, NY - Oct 25, 2019 - Since its establishment in 2004, Creative Proteomics has gradually been a leading supplier providing proteomics, glycomics, metabolomics and bioinformatics analysis services
Oct 24, 2019
-
Spring Bank Announces Interim Top-Line Results from the First Cohort of the Phase 2 Trial Evaluating Low-Dose Inarigivir Plus Vemlidy® in Chronic Hepatitis B Patients
HOPKINTON, MA, UNITED STATES - Oct 17, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced interim top-line results at 12 weeks from the first cohort of the ongoing Phase 2 trial evaluating the safety, efficacy and pharmacodynamics of escalating doses (50mg, 200mg and 400mg) of the investigational compound inarigivir co-administered with Gilead Sciences Vemlidy® (tenofovir alafenamide 25mg) for the treatment of chronic hepatitis B virus (HBV) infection
Oct 24, 2019
-
KCR Announces new Chief Technology Officer
BOSTON, MA, US - Oct 24, 2019 - KCR, an international clinical development solutions provider, has named Douglas Bain the organizations Chief Technology Officer
Oct 24, 2019
-
TrialScope Acquires Clinical Trial Connect
JERSEY CITY, NJ, US - Oct 24, 2019 - TrialScope, the global leader in transparency and disclosure compliance solutions, has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials
Oct 24, 2019
-
MR Solutions’ new preclinical imaging PET/CT range on display at EANM ‘19
GUILDFORD, UNITED KINGDOM - Oct 24, 2019 - MR Solutions has launched a complete range of advanced PET/CT preclinical imaging systems at EANM 19, (European Association of Nuclear Medicine) last week in Barcelona
Oct 24, 2019
-
ZEISS expands its portfolio of microscope cameras
CHICAGO, IL, UNITED STATES - Oct 23, 2019 - ZEISS introduces four new high-quality CMOS cameras for digital imaging in light microscopy. These cameras complete the portfolio of proven ZEISS Axiocam models which stand for excellent performance in demanding microscopy applications
Oct 23, 2019
-
Accumen Acquires Medical Imaging Post-Processing Company 3DR Laboratories
PHOENIX, AZ - Oct 22, 2019 - Accumen Inc., the leader in healthcare performance, today announced that it has acquired 3DR Laboratories, the largest and most respected 3D medical post-processing laboratory in the United States
Oct 22, 2019
-
Leading Pediatric Cancer Center Selects Petagene’s Genomic Data Compression Solutions for Informatics Infrastructure
CAMBRIDGE, UK - Oct 22, 2019 - PetaGene today announced that Princess Máxima Center for Pediatric Oncology, the largest pediatric cancer center in Europe, has chosen to use PetaGenes transparent, lossless genomic data compression software, called PetaSuite, to reduce its data storage costs while accelerating access to the data
Oct 22, 2019
-
As Demand for RBx Soars CluePoints Continues Global Expansion Alongside Further Award Wins
KING OF PRUSSIA, PA - Oct 22, 2019 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced major expansion as it bolsters its offering with two new larger offices to accommodate its growing family of employees and contractors
Oct 22, 2019
-
Enhancing ZEISS Celldiscoverer 7 with ZEISS LSM 900 for optical sectioning
- Oct 21, 2019 - The proven ZEISS Celldiscoverer 7 is a fully integrated high-end imaging system with various incubation and detection options
Oct 21, 2019
-
UKI2S Innovate Accelerator reaches entrepreneurial start-ups in all parts of the UK
LONDON, UK - Oct 21, 2019 - Sciad Newswire / The UK Innovation & Science Seed Fund (UKI2S) has celebrated the first anniversary of its UKI2S Innovate Accelerator, a joint funding initiative with Innovate UK (IUK) directed at early stage science and engineering companies
Oct 21, 2019
-
MGI Demonstrates Success of New CoolMPS™ Sequencing Chemistry on PCR-free DNBSEQ™ Platform
HOUSTON, TX, UNITED STATES - Oct 18, 2019 - MGI, a subsidiary of global genomics leader BGI Group, said early research results from its revolutionary CoolMPS proprietary sequencing technology performed with high accuracy, reproducibility and cost effectiveness, leading the way toward more efficient and accurate Massively Parallel Sequencing (MPS)
Oct 18, 2019
-
PetaGene announces collaboration with AstraZeneca to deploy its genomic data compression software in core genomics initiative
CAMBRIDGE, UK - Oct 18, 2019 - PetaGene announced today that their PetaSuite software has been selected to compress the genomics data sets for AstraZenecas Centre for Genomics Research (CGR)
Oct 18, 2019
-
Amplion's Machine Learning Platform Accelerates Precision Medicine Collaboration
BEND, OR, UNITED STATES - Oct 16, 2019 - - Effective partnerships between pharmaceutical companies, biotechs, academia, diagnostic companies, CROs and other players along the drug development continuum are vital to achieving the realization of precision medicine- For diagnostic and test providers in particular, identifying the right pharma partnering opportunities at the right time can be daunting, yet it's critical for gaining early traction and establishing long-term profitable relationships- Amplion's Dx:Revenue solution plays an important role in aiding test providers in finding and targeting these elusive pharma partnering opportunities through relevant and timely insightsAmplion, a leading precision medicine intelligence company, has released Dx:Revenue, a groundbreaking software solution that enables test providers to identify ideal pharmaceutical partnership opportunities at the right time to advance precision medicine collaboration
Oct 16, 2019
-
BioIVT Acquires PPA Research Group, Increasing its Ability to Support Drug Development, Cell and Gene Therapy Research
WESTBURY, NY - Oct 16, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired PPA Research Group, Inc
Oct 16, 2019
-
iGenomX Launches Next-Generation Genotyping Application to Propel the Future of Population-Scale Genomics Research
HOUSTON, TX, UNITED STATES - Oct 15, 2019 - iGenomX International Genomics Corp., provider of the industrys most scalable sequencing library tools, today launched its Next-Generation Genotyping (NGG) application for population-scale genomic research
Oct 15, 2019
-
The University of Bristol Selects Signant Health’s TrialConsent® to Assess the Impact and Value of eConsent in an Oncology Trial
PHILADELPHIA, PA, UNITED STATES - Oct 14, 2019 - The National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC) at the University of Bristol has selected Signant Health, formerly CRF Health and Bracket, as its partner to provide electronic informed consent (eConsent) support for an oncology trial
Oct 14, 2019